KMID : 1034820090050040298
|
|
Molecular & Cellular Toxicology 2009 Volume.5 No. 4 p.298 ~ p.303
|
|
Pharmacokinetic and Pharmacodynamic Interaction between Metformin and (-)-Epigallocatechin-3-gallate
|
|
Ko Jeong-Hyeon
Jang Eun-Hee Park Chang-Shin Kim Hyoung-Kwang Cho Soon-Gu Shin Dong-Wun Yi Hyeon-Gyu Cho Ji-Yoon
|
|
Abstract
|
|
|
(-)-Epigallocatechin-3-gallate (EGCG), a major flavonoid in green tea has multiple health benefits including chemoprevention, anti-inflammatory, anti-diabetic, and anti-obesity effects. In connection with these effects, EGCG can be a candidate to help the treatment of metabolic diseases. Metformin is a widely used anti-diabetic drug regulating cellular energy homeostasis via AMP-activated protein kinase (AMPK) activation. Therefore, the combination of metformin with EGCG may have additive or synergistic effects on treatment of type 2 diabetes. Nevertheless, there is no report for the pharmacokinetic and/or pharmacodynamic interaction of EGCG with metformin. Here, we evaluated the pharmacokinetic and pharmacodynamic interaction between metformin and EGCG in rats. Pharmacokinetics parameters of metformin were measured after oral administration of metformin in rats pre-treated with EGCG (10 mg/kg) or saline for 7 days. The results showed that there is no significant difference in pharmacokinetic parameters between saline control and EGCG-treated group. In addition, the hepatic AMPK activation by metformin in EGCG-treated rats was also similar to the control. The lack of additive effects of EGCG on AMPK activation or intracellular uptake of metformin was also evaluated in cells in the presence or absence of EGCG. Treatment of HepG2 cells with EGCG inhibited the metformin-induced AMPK activation. Combined results suggested that EGCG has no effect on the pharmacokinetics of metformin but may contribute to metformin action.
|
|
KEYWORD
|
|
(-)-Epigallocatechin-3-gallate, Metformin, Pharmacokinetics, AMP-activated protein kinase
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|